Skip to content

Clinical trials

Phase 2 Lymphoma, Mantle-Cell trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Mantle-Cell Phase: Phase 2 Country / region: Belgium Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20081
20091
20121
20131
20152
20171
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting2
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Celgene2
Janssen Research & Development, LLC2
The Lymphoma Academic Research Organisation2
Acerta Pharma BV1
European Organisation for Research and Treatment of Cancer - EORTC1
Incyte Corporation1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Mantle-Cell10
Lymphoma, Non-Hodgkin4
Lymphoma, Follicular3
Lymphoma, Large B-Cell, Diffuse3
Lymphoma2
Ataxia Telangiectasia1
Blast Crisis1
Breast Neoplasms1
Burkitt Lymphoma1
Carcinoma, Ovarian Epithelial1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.